The latest price target for Axogen (NASDAQ:AXGN) was reported by JMP Securities on August 9, 2024. The analyst firm set a price target for $20.00 expecting AXGN to rise to within 12 months (a possible 44.20% upside). 7 analyst firms have reported ratings in the last year.

The latest analyst rating for Axogen (NASDAQ:AXGN) was provided by JMP Securities, and Axogen maintained their market outperform rating.

The last upgrade for Axogen Inc happened on May 9, 2022 when Canaccord Genuity raised their price target to $15. Canaccord Genuity previously had a hold for Axogen Inc.

There is no last downgrade for Axogen.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.

While ratings are subjective and will change, the latest Axogen (AXGN) rating was a maintained with a price target of $17.00 to $20.00. The current price Axogen (AXGN) is trading at is $13.87, which is out of the analyst’s predicted range.